{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:04:33Z","timestamp":1765040673672},"reference-count":46,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.vaccine.2017.03.042","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T09:33:30Z","timestamp":1490693610000},"page":"2372-2378","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Sociodemographic predictors of variation in coverage of the national shingles vaccination programme in England, 2014\/15"],"prefix":"10.1016","volume":"35","author":[{"given":"Charlotte","family":"Ward","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne M.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayatri","family":"Amirthalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Tiley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Edelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2017.03.042_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-14-402","article-title":"Burden of herpes zoster in the UK: findings from the zoster quality of life (ZQOL) study","volume":"14","author":"Gater","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.042_b0010","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.vaccine.2008.12.024","article-title":"Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales","volume":"27","author":"Van Hoek","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.03.042_b0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1017\/S0950268808000678","article-title":"Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom","volume":"137","author":"Gauthier","year":"2009","journal-title":"Epidemiol Infect"},{"issue":"22","key":"10.1016\/j.vaccine.2017.03.042_b0020","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2017.03.042_b0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1090-3801(99)90015-0","article-title":"The lifetime occurrence of Herpes zoster and prevalence of post-herpetic neuralgia: a retrospective survey in an elderly population","volume":"3","author":"Bowsher","year":"1999","journal-title":"Eur J Pain"},{"issue":"3","key":"10.1016\/j.vaccine.2017.03.042_b0030","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/S0950268800004714","article-title":"Modelling the impact of immunization on the epidemiology of varicella zoster virus","volume":"125","author":"Brisson","year":"2000","journal-title":"Epidemiol Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2017.03.042_b0035","doi-asserted-by":"crossref","DOI":"10.1097\/00013542-199310000-00006","article-title":"Epidemiology, outcome and control of varicella-zoster infection","volume":"4","author":"Miller","year":"1993","journal-title":"Rev Med Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.03.042_b0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/j.pain.0000000000000307","article-title":"A systematic review and meta-analysis of risk factors for postherpetic neuralgia","volume":"157","author":"Forbes","year":"2016","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.vaccine.2017.03.042_b0045","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1212\/01.WNL.0000123261.00004.29","article-title":"Risk factors for postherpetic neuralgia in patients with herpes zoster","volume":"62","author":"Jung","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.vaccine.2017.03.042_b0050","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jama.2010.1983","article-title":"Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease","volume":"305","author":"Tseng","year":"2011","journal-title":"Jama"},{"key":"10.1016\/j.vaccine.2017.03.042_b0055","unstructured":"Government of Alberta. Health Information Act: Health Information Regulation (Alberta Regulation 70\/2001 with amendments up to and including Alberta Regulation 49\/2014). Alberta Regulation 70\/2001, 2014. Health Information Act: Health Information Regulation."},{"key":"10.1016\/j.vaccine.2017.03.042_b0060","first-page":"2010","volume":"29","author":"Joint Committee on Vaccination and Immunisation","year":"2010","journal-title":"Statement on varicella and herpes zoster vaccines"},{"key":"10.1016\/j.vaccine.2017.03.042_b0065","unstructured":"Public Health England. Herpes zoster (shingles) vaccination programme to protect the elderly. HPR 7(35): News, 30 August 2013 2013 <http:\/\/webarchive.nationalarchives.gov.uk\/20140714084352\/http:\/www.hpa.org.uk\/hpr\/archives\/2013\/news3513.htm#shngls>."},{"key":"10.1016\/j.vaccine.2017.03.042_b0070","unstructured":"Public Health England. Herpes zoster (shingles) immunisation programme 2013\/2014: Report for England; 2014 <https:\/\/www.gov.uk\/government\/publications\/herpes-zoster-shingles-immunisation-programme-2013-to-2014-evaluation-report>."},{"key":"10.1016\/j.vaccine.2017.03.042_b0075","unstructured":"NHS England. Public Health Section 7A Commissioning Intentions, 2015\/16; 2015 <https:\/\/www.england.nhs.uk\/commissioning\/wp-content\/uploads\/sites\/12\/2014\/12\/ph-comms-intent-15-16.pdf>."},{"key":"10.1016\/j.vaccine.2017.03.042_b0080","unstructured":"Legislation.gov.uk, Equality Act 2010; 2010."},{"issue":"41","key":"10.1016\/j.vaccine.2017.03.042_b0085","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1016\/j.vaccine.2013.07.053","article-title":"Trends and disparity in zoster vaccine uptake in a managed care population","volume":"31","author":"Hechter","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.03.042_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-14-1098","article-title":"Herpes zoster vaccine (HZV): utilization and coverage 2009\u20132013, Alberta, Canada","volume":"14","author":"Liu","year":"2014","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2017.03.042_b0095","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/jech.2008.085142","article-title":"Inequalities in immunisation and breast feeding in an ethnically diverse urban area: cross-sectional study in Manchester, UK","volume":"65","author":"Baker","year":"2011","journal-title":"J Epidemiol Community Health"},{"issue":"8","key":"10.1016\/j.vaccine.2017.03.042_b0100","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.vaccine.2010.12.030","article-title":"Attitudinal and demographic predictors of measles, mumps and rubella (MMR) vaccine acceptance: development and validation of an evidence-based measurement instrument","volume":"29","author":"Brown","year":"2011","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2017.03.042_b0105","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1016\/j.vaccine.2015.03.049","article-title":"Phased introduction of a universal childhood influenza vaccination programme in England: population-level factors predicting variation in national uptake during the first year, 2013\/14","volume":"33","author":"Green","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2017.03.042_b0110","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/archdischild-2013-304388","article-title":"Childhood vaccination coverage by ethnicity within London between 2006\/2007 and 2010\/2011","volume":"99","author":"Wagner","year":"2014","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1016\/j.vaccine.2017.03.042_b0115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/sextrans-2013-051179","article-title":"Uptake of the HPV vaccination programme in England: a cross-sectional survey of young women attending sexual health services","volume":"90","author":"Sacks","year":"2014","journal-title":"Sex Transm Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2017.03.042_b0120","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/pubmed\/fdt042","article-title":"Examining inequalities in the uptake of the school-based HPV vaccination programme in England: a retrospective cohort study","volume":"36","author":"Fisher","year":"2014","journal-title":"J Public Health (Oxf)"},{"issue":"43","key":"10.1016\/j.vaccine.2017.03.042_b0125","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1016\/j.vaccine.2015.08.093","article-title":"What determines uptake of pertussis vaccine in pregnancy? A cross sectional survey in an ethnically diverse population of pregnant women in London","volume":"33","author":"Donaldson","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.042_b0130","doi-asserted-by":"crossref","unstructured":"Hughes A, et al. Coverage of the English national human papillomavirus (HPV) immunisation programme among 12\u201317 year-old females by area-level deprivation score, England, 2008 to 2011. Euro Surveill 2014;19(2).","DOI":"10.2807\/1560-7917.ES2014.19.2.20677"},{"issue":"03","key":"10.1016\/j.vaccine.2017.03.042_b0135","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1017\/S095026881000066X","article-title":"Human papillomavirus vaccination and social inequality: results from a prospective cohort study","volume":"139","author":"Roberts","year":"2011","journal-title":"Epidemiol Infect"},{"issue":"7553","key":"10.1016\/j.vaccine.2017.03.042_b0140","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/bmj.332.7553.1312","article-title":"Differences in risk factors for partial and no immunisation in the first year of life: prospective cohort study","volume":"332","author":"Samad","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2017.03.042_b0145","unstructured":"GOV.UK. ImmForm, 6 November 2013 <https:\/\/www.gov.uk\/government\/collections\/immform>."},{"key":"10.1016\/j.vaccine.2017.03.042_b0150","volume":"13","author":"Office for National Statistics","year":"2016","journal-title":"Presenting ethnic and national groups data."},{"key":"10.1016\/j.vaccine.2017.03.042_b0155","unstructured":"Office for National Statistics. Open geography portal; 2011 <http:\/\/webarchive.nationalarchives.gov.uk\/20160105160709\/https:\/\/geoportal.statistics.gov.uk\/geoportal\/catalog\/main\/home.page>."},{"key":"10.1016\/j.vaccine.2017.03.042_b0160","unstructured":"HSCIC. Numbers of Patients Registered at a GP Practice - April 2016; 2016 <http:\/\/www.hscic.gov.uk\/article\/2021\/Website-Search?productid=20718&q=GP+patient+number&sort=Relevance&size=10&page=1&area=both#top>."},{"key":"10.1016\/j.vaccine.2017.03.042_b0165","unstructured":"Office for National Statistics. Super Output Area (SOA). 06\/01\/2016 <http:\/\/webarchive.nationalarchives.gov.uk\/20160105160709\/http:\/\/www.ons.gov.uk\/ons\/guide-method\/geography\/beginner-s-guide\/census\/super-output-areas--soas-\/index.html>."},{"key":"10.1016\/j.vaccine.2017.03.042_b0170","unstructured":"Office for National Statistics. 2011 Census: Key Statistics for England and Wales, March 2011; 2012 <http:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates\/bulletins\/2011censuskeystatisticsforenglandandwales\/2012-12-11>."},{"issue":"9","key":"10.1016\/j.vaccine.2017.03.042_b0175","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/jech.2005.045633","article-title":"Ethnicity as a correlate of the uptake of the first dose of mumps, measles and rubella vaccine","volume":"61","author":"Mixer","year":"2007","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.vaccine.2017.03.042_b0180","unstructured":"Public Health England. Rotavirus vaccine uptake report for England: February 2014 to March 2015; 2015 <https:\/\/www.gov.uk\/government\/publications\/rotavirus-vaccine-uptake-report-for-england>."},{"key":"10.1016\/j.vaccine.2017.03.042_b0185","unstructured":"Public Health England. Pertussis vaccine coverage in pregnant women April 2014 to March 2015; 2015 <https:\/\/www.gov.uk\/government\/publications\/pertussis-vaccine-coverage-in-pregnant-women-april-2014-to-march-2015>."},{"key":"10.1016\/j.vaccine.2017.03.042_b0190","unstructured":"Public Health England. HPV vaccination coverage report: 1 September 2014 to 31 August 2015; 2015 <https:\/\/www.gov.uk\/government\/statistics\/annual-hpv-vaccine-coverage-2014-to-2015-by-local-authority-and-area-team>."},{"key":"10.1016\/j.vaccine.2017.03.042_b0195","unstructured":"Public Health England. Vaccination coverage statistics, England (COVER programme): April 2015 to March 2016; 2016 <https:\/\/www.gov.uk\/government\/publications\/cover-of-vaccination-evaluated-rapidly-cover-programme-annual-data>."},{"issue":"6905","key":"10.1016\/j.vaccine.2017.03.042_b0200","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/bmj.307.6905.681-b","article-title":"Improving uptake of immunisation. Mobile children miss out","volume":"307","author":"Barret","year":"1993","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.vaccine.2017.03.042_b0205","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001453","article-title":"Poor uptake of primary healthcare registration among recent entrants to the UK: a retrospective cohort study","volume":"2","author":"Stagg","year":"2012","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.vaccine.2017.03.042_b0210","first-page":"456","article-title":"Parental views on childhood vaccination against viral gastroenteritis\u2014a qualitative interview study","volume":"32","author":"Lugg","year":"2015","journal-title":"Family Practice"},{"issue":"8","key":"10.1016\/j.vaccine.2017.03.042_b0215","doi-asserted-by":"crossref","first-page":"566","DOI":"10.12968\/bjom.2015.23.8.566","article-title":"Attitudes to immunisation in pregnancy among women in the UK targeted by such programmes","volume":"23","author":"Campbell","year":"2015","journal-title":"Brit J Midwif"},{"issue":"2","key":"10.1016\/j.vaccine.2017.03.042_b0220","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.vaccine.2008.10.047","article-title":"Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly","volume":"27","author":"Opstelten","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.042_b0225","unstructured":"Public Health England. Herpes zoster (shingles) immunisation programme 2014 to 2015: report for England; 2015."},{"issue":"3","key":"10.1016\/j.vaccine.2017.03.042_b0230","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/pubmed\/fdt052","article-title":"Mapping the Gypsy Traveller community in England: what we know about their health service provision and childhood immunization uptake","volume":"35","author":"Dar","year":"2013","journal-title":"J Public Health (Oxf)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T01:23:48Z","timestamp":1535937828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17303584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":46,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0264410X17303584"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sociodemographic predictors of variation in coverage of the national shingles vaccination programme in England, 2014\/15","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}